Tuesday 13 October 2026
Export ALT’s income statement to Excel — free account
Altimmune, Inc.
Altimmune, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41,000.00, up 105.0% from fiscal 2024. In the quarter to June 2026, revenue grew 520.0%, EPS grew 55.6%, free cash flow fell 25.3% and total debt rose 142.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.48
0.08
−3.13%
Follow ALT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
2 | 4 | 3 | 3 | 4 | 2 | — | — | 2 | 4 |
Altman Z-Score |
— | (3.25) | (4.08) | (2.17) | 8.32 | 9.20 | 18.47 | 18.25 | 12.45 | 0.23 |
P/S ratio |
0.00 | 2.41 | 0.56 | 4.28 | 35.33 | 85.75 | 0.00 | 1,314.92 | 25,596.73 | 6,914.26 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
0.70 | (5.77) | (0.16) | (0.93) | 14.19 | 8.83 | 5.76 | 8.19 | (3.94) | 0.63 |
Beneish M-Score |
(0.21) | (0.80) | (5.99) | (3.96) | 1.38 | (3.77) | — | — | 6.02 | (3.17) |
P/Operating CF |
0.00 | (5.39) | (1.12) | (12.39) | (21.77) | (17.21) | (42.38) | (33.88) | (28.03) | (16.35) |
P/B ratio |
0.00 | 0.66 | 0.12 | 0.55 | 1.28 | 1.90 | 3.96 | 2.89 | 4.15 | 1.41 |
Price to Tangible BV |
0.00 | 38.48 | 0.17 | 0.76 | 1.36 | 2.03 | 4.24 | 3.08 | 4.61 | 1.50 |
EV/Sales |
(0.81) | 1.32 | (2.69) | (1.86) | 9.15 | 42.88 | (8,079.20) | 851.59 | 19,023.93 | 1,717.80 |
EV/EBITDA |
0.24 | 0.00 | 1.58 | 0.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.41 | (0.70) | 2.96 | 1.13 | (2.18) | (2.42) | (8.78) | (4.79) | (4.76) | (1.17) |
EV/FCF |
0.40 | (0.70) | 2.68 | 1.12 | (2.16) | (2.09) | (8.73) | (4.77) | (4.75) | (1.17) |
Quick Ratio |
0.74 | 5.85 | 8.58 | 9.92 | 19.00 | 10.73 | 10.99 | 16.69 | 12.90 | 18.35 |
Current Ratio |
0.82 | 6.11 | 8.70 | 10.04 | 19.16 | 11.17 | 11.31 | 17.26 | 13.11 | 18.55 |
Net Debt/EBITDA |
0.26 | 0.77 | 1.92 | 1.78 | 3.95 | 1.96 | 2.10 | 2.31 | 1.24 | 2.49 |
Debt/Assets |
0.04% | 0.00% | 0.92% | 2.75% | 0.60% | 0.51% | 0.32% | 0.00% | 0.00% | 12.25% |
Debt/Equity |
0.00 | 0.00 | 0.01 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.15 |
Asset Turnover |
0.11 | 0.21 | 0.18 | 0.11 | 0.05 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.55 | 0.39 | 0.22 | 0.46 | 0.70 | 0.81 | 0.74 | 0.86 | 0.84 | 0.77 |
Capex/Depreciation |
(1.63) | 0.00 | (0.04) | (0.07) | (0.80) | (22.34) | 0.61 | 0.00 | 0.00 | 0.01 |
Interest Coverage |
(288.10) | (321.07) | (144.17) | (9,302.23) | (5,829.65) | (19,382.80) | (10,967.50) | (2,740.83) | (11,463.56) | (57.76) |
| (46.90%) | (143.46%) | (96.86%) | (44.70%) | (36.14%) | (45.69%) | (44.07%) | (46.63%) | (59.86%) | (50.57%) | |
| (39.32%) | (101.26%) | (72.13%) | (38.55%) | (32.79%) | (41.85%) | (39.79%) | (42.36%) | (54.33%) | (42.03%) | |
ROIC |
(23.62%) | (120.07%) | (185.13%) | (131.45%) | (300.78%) | (610.37%) | (5,217.65%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
1,421.79% | (253.87%) | (117.39%) | (57.34%) | (22.36%) | (51.84%) | (47.90%) | (44.64%) | (74.73%) | (33.43%) |
Average Days of Receivables |
134.28 | 345.61 | 157.96 | 103.83 | 551.76 | 483.27 | (13,639.19) | 4,158.09 | 56,885.25 | 15,463.54 |
Research and Development Expense of Revenue |
223.15% | 171.41% | 178.68% | 306.23% | 608.12% | 1,690.27% | (103,732.35%) | 15,445.77% | 411,130.00% | 162,029.27% |
Selling, General and Administrative Expense of Revenue |
219.59% | 78.76% | 94.53% | 146.53% | 161.39% | 349.50% | (25,197.06%) | 4,257.51% | 104,830.00% | 68,531.71% |
Intangible Assets out of Total Assets |
0.88 | 0.61 | 0.25 | 0.24 | 0.05 | 0.06 | 0.06 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
29.83% | 13.44% | 7.48% | 21.79% | 31.47% | 125.15% | (11,913.24%) | 2,497.65% | 71,965.00% | 39,209.76% |
Graham Net Nets |
(247.02) | (0.01) | 5.70 | 1.24 | 0.73 | 0.49 | 0.23 | 0.34 | 0.24 | 0.70 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
2,962,960.00% | (178.27%) | (844.58%) | (80.42%) | (16.93%) | (25.76%) | (11.32%) | (15.68%) | (18.59%) | (27.98%) |
Free Cash Flow Yield |
(93,802.49%) | (78.62%) | (179.98%) | (38.82%) | (11.98%) | (23.95%) | (8.58%) | (13.58%) | (15.64%) | (21.30%) |
Revenue per Share |
14.06 | 24.86 | 3.69 | 0.44 | 0.32 | 0.11 | 0.00 | 0.01 | 0.00 | 0.00 |
Operating CF per Share |
(27.60) | (46.80) | (3.35) | (0.73) | (1.34) | (1.90) | (1.33) | (1.42) | (1.12) | (0.77) |
Capex per Share |
(0.96) | (0.37) | (0.36) | 0.00 | (0.01) | (0.30) | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(28.56) | (47.17) | (3.71) | (0.73) | (1.35) | (2.19) | (1.34) | (1.42) | (1.12) | (0.77) |
Cash per Share |
12.49 | 28.49 | 12.26 | 2.84 | 8.42 | 4.61 | 3.94 | 3.72 | 1.86 | 3.10 |
Shareholders Equity per Share |
139.91 | 91.22 | 17.24 | 3.47 | 8.81 | 4.82 | 3.95 | 3.65 | 1.74 | 2.55 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
139.91 | 91.22 | 17.24 | 3.47 | 8.81 | 4.82 | 3.95 | 3.65 | 1.74 | 2.55 |
Free Cash Flow |
(6.57) | (20.37) | (10.39) | (9.63) | (34.65) | (90.55) | (62.71) | (75.86) | (79.85) | (67.55) |
Working Capital |
(0.98) | 19.63 | 34.84 | 35.47 | 218.24 | 185.85 | 175.76 | 197.48 | 126.79 | 263.20 |
Capital Expenditures |
(0.22) | (0.16) | (1.00) | (0.03) | (0.34) | (12.31) | (0.13) | (0.05) | — | (0.01) |
Net Current Asset Value |
(1.71) | (0.17) | 32.93 | 30.86 | 211.02 | 184.40 | 171.18 | 193.09 | 121.46 | 223.16 |
EV/EBIT |
0.24 | 0.00 | 0.65 | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.07 | 0.01 | 0.10 | 0.01 | 0.04 | 2.79 | (1.85) | 0.11 | 0.00 | 0.27 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.76 | 59.79 | 18.80 | 0.35 | 0.41 | 0.38 | (0.19) | 16.01 | (8.75) | (5.61) |
Cash ROIC |
(18.73%) | (39.41%) | (12.49%) | (11.43%) | (7.82%) | (23.18%) | (16.91%) | (19.35%) | (31.26%) | (12.68%) |
Accounts Receivable Turnover |
2.43 | 1.89 | 1.41 | 1.90 | 1.17 | 0.48 | (0.02) | 0.12 | 0.01 | 0.02 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Average Receivables |
1.33 | 5.68 | 7.32 | 3.06 | 7.01 | 9.11 | 4.19 | 3.70 | 3.99 | 2.43 |
Average Payables |
1.26 | 1.07 | 0.25 | 0.20 | 0.32 | 1.32 | 3.42 | 3.44 | 1.14 | 1.46 |
Average Assets |
29.13 | 50.72 | 58.89 | 54.40 | 149.59 | 231.99 | 212.90 | 208.78 | 174.97 | 209.62 |
Average Common Equity |
24.43 | 35.80 | 43.85 | 46.92 | 135.70 | 212.51 | 192.21 | 189.70 | 158.80 | 174.20 |
Columns are period end dates